Albemarle Corporation Fine Chemicals

1. Albemarle CorporationFine Chemicals UBS Grass Roots Chemical Conference February 16, 2005 John Nicols Vice President Fine Chemicals

2. Cautionary Statement Some of this presentation constitutes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Although Albemarle Corporation believes its expectations reflected in the presentation are based on reasonable assumptions within the bounds of its knowledge of its business and operations, there can be no assurance that actual results will not differ materially. Factors that could cause actual results to differ from expectations include, without limitation, the timing of orders received from customers; the gain or loss of significant customers; competition from other manufacturers; changes in demand for our products; increases in the cost of raw materials and energy, and our inability to pass through such increases to our customers; changes in the market in general; fluctuations in foreign currencies; significant changes in new product introductions, resulting in increased capital spending; and the integration of the Akzo Nobel Refinery Catalysts business into our operations. Additional factors that could cause Albemarle’s results to differ materially from those described in the forward-looking statements can be found in our prospectus dated January 13th, 2005, filed pursuant to SEC Rule 424(b).

3. Albemarle History 1887 - Albemarle Paper Manufacturing Company opens with a handful of employees producing Kraft and blotting paper. 1921 - The antiknock properties of tetraethyl lead (TEL) as a gasoline additive are discovered after a lengthy search by a team of General Motors research chemists. TEL is to be the principal product of Ethyl Corporation for more than 40 years. 1942 - Ethyl Gasoline Corporation changes its name to Ethyl Corporation to characterize a broader interest than just gasoline products. 1962 - Albemarle Paper Manufacturing Company borrows $200 million and purchases Ethyl Corporation (Delaware), a corporation 13 times its size, and Ethyl Corporation (Virginia) is formed. Floyd D. Gottwald becomes Chairman of the Board. 1976 - Ethyl leaves paper manufacturing with the sale of Oxford Paper. Ethyl opens a chemical plant in Feluy, Belgium to make aluminum alkyls. 1996 - Albemarle sells its alpha olefins, polyalphaolefins and synthetic alcohols businesses to Amoco for about $500 million. 1998 - Albemarle energizes M&A effort to grow the company based on longstanding foundation technologies of bromine and organometallic chemistry, supported by exceptional skill in process technology. 1987 - Ethyl acquires Dow Chemical's bromine chemicals business and its Magnolia, Arkansas, plant. 1994 - Ethyl spins off its chemical businesses to create an independent, publicly traded company named Albemarle Corporation

4. Fine ChemicalsJV / Acquisition Activity 2004 2003 2002 Acquired assets of Korean distributor of Albemarle; other products Acquired lube and fuel anti-oxidants of Ethyl Acquired Phosphorus Flame Retardants of Rhodia 2001 Formed Stannica JV with Atofina—crude tin stabilizers for PVC Announced China Trading Company 2000 Acquired Martinswerk-- Largest global mineral based FR and Performance Chemicals Acquired ChemFirst Fine Chemicals; Integrated with ALB to form Fine Chemistry Services 1999 Acquired Ferro BrPS FR Bus Took ownership In Jinhai Polymer & Expanded 2X Tender Offer For A&W; Created Cash Gain Formed Jordan Bromine Co; Started Project for ’02 Startup Acquired refining catalyst segment of Akzo Nobel Acquired Atofina S.A. Bromine Fine Chemicals

5. Company Overview Albemarle is a global producer of specialty chemicals with leading market positions in a majority of its product lines • Diversified mix of solution-based products sold to a wide range of customers and end markets • Over 3,400 customers • End markets include consumer electronics, petroleum refining, packaging, construction, automotive, pharmachemicals and agrichemicals • Broad geographic footprint • Sales in approximately 100 countries • 38 locations (inc. JVs) in North and South America, Europe and Asia • Approximately 3,700 employees worldwide • 2004 Results (1) • Net Sales $1,514 million • Net Income $76 million (up 13% over 2003) • EPS $1.78 Albemarle provides innovative development, manufacturing and marketing of complex chemicals and services that create exceptional customer value while maximizing shareholder wealth. (1) Year ending December 31, 2004 includes 5 months refinery catalysts business. Excludes special items, unaudited results

6. Manufacturing Facility Business Center Americas Europe Asia 42% 38% 20% 2004 Sales (ex. JVs) Broad Geographic Reach Worldwide manufacturing complemented by sales, marketing and distribution facilities in each of the world’s key regions Teesport, UK Avonmouth, UK Amsterdam, The Netherlands Amersfoort, The Netherlands Bergheim, Germany Tyrone, PA, USA Dayton, OH, USA Beijing, China Louvain-la-Neuve, Belgium Seoul, Korea Richmond, VA, USA St. Jakob/Breitenau, Austria (JV) Feluy, Belgium Orangeburg, SC, USA La Voulte, France (JV) Thann, France Port-de-Bouc, France Baton Rouge, LA, USA Tokyo, Japan Magnolia, AR, USA Osaka, Japan, (NAA JV) Pasadena, TX, USA Safi, Jordan (JBC JV) Niihama, Japan (Nippon Ketjen JV) Houston, TX, USA Shanghai, China (JVs) Singapore Zhejiang Province, China Santa Cruz, Brazil (FCC SA JV) R&D Facility

7. Albemarle Corporation Today • Refinery Catalysts acquired July 31, 2004 for €616 million ($763 million) • Significantly enhances existing business by adding attractive strong specialty chemicals platform • Leading positions in a market with strong industry fundamentals • Proprietary technology and service-driven business model • Strong margins and cash flows • Potential technology, raw material and other cost synergies • Balanced portfolio with common technology Catalysts Approx. Net Sales Distribution • Leading positions in refinery and metallocene catalysts • History of innovation • Strong customer relationships • Global scope and reputation 29% 41% Polymer Additives 30% • Bromine integration • Leading positions in major flame retardant chemistries • Additives niches • Global scope and reputation Fine Chemicals

8. Leading Market Positions in Major Product Categories Foundation Chemistries Solutions-Based Product Portfolio Leading Global Market Positions Flame Retardants Catalysts Plastic Additives Fuel Additives Agrichemicals Pharmaceuticals Performance Chemicals Bromine-based FRs Mineral FRs HPC Catalysts FCC Catalysts Alkyl Co-Catalysts Metallocene Co-Catalysts Alkylated Anilines Bromine Ibuprofen Process Technology Innovation Application “Know-How” Service Leading Customer Relationships Bromine Phosphorus Alumina Orthoalkylation Metal Alkyls Albemarle’s Formula for Success Source: Industry Research and Management Estimates.

9. Key Strategic Principles • Leverage Foundation Businesses and Technologies • Innovation allows for management of product rotation • Customer-driven product line expansions • Focus on higher-margin, solution-based products and services • Expand Global Reach • Expand with new and existing multinational customers • Target high-growth economies • Drive Low-Cost Manufacturing and Continuous Operational Improvement • Continuous cost reduction efforts • Flexible, multi-purpose sites • Establish Superior Customer and Technology Relationships • Drive innovation in regulatory-driven markets • Provide value-added products and services • Develop business with less capital and risk

10. Fine Chemicals

11. Albemarle Fine ChemicalsProduct DiversityStrategic Clusters Ag Actives Fine Chemistry Services Pharma Actives (APIs) Services & Intermediates Others Industrial Specialties Alumina Specialties Paper Chemicals K & Cl2 Derivatives Tertiary Amines Bromine Chemicals Bromine Specialties Oilfield Chemicals Br2 & Derivatives

12. Fine Chemicals Strategies Serve Chemistry To Solve Customer Problems ------------------------------------------------------- Widen & Deepen Access Into Key End Markets: Pharma & Ag ------------------------------------------------------- Drive To Actives: Highest Chemistry Value Add Fine Chemistry Services Industrial Specialties StrategicGrowth Manage for Cash New Strategy Potentials ? Bromine Chemicals Leading Bromine Company Worldwide

13. Fine Chemicals Strategies Serve Chemistry To Solve Customer Problems ------------------------------------------------------- Widen & Deepen Access Into Key End Markets: Pharma & Ag ------------------------------------------------------- Drive To Actives: Highest Chemistry Value Add Fine Chemistry Services Industrial Specialties StrategicGrowth Manage for Cash New Strategy Potentials ? Bromine Chemicals Leading Bromine Company Worldwide

14. World-Class Bromine Position Other14% FlameRetardants 40% Albemrle holds strong positions in each of the key areas of the world’s bromine-using industries. Pharma3% Capturing growth through strong positions in key areas of the world’s bromine-using industries WaterTreatment7% Ag12% Albemarle Bromine Production Oilfield 24% 350 10-year CAGR = 7.5% 300 Low cost domestic reserves augmented by JV production on the Dead Sea 250 M Lbs. 200 150 Bromine-Industry Usage - 2002 USGS/Mining Engineering June 2003 100 ’94 ’95 ’96 ’97 ’98 ’99 ’00 ’01 ’02 ’03 ’04

15. 2003 AtoFina BFC Acquired 1980 Saytech Acquired 1987 Dow Br & FR Business Acquired 1993 Thann Acquired 2000 Ferro BrFRs Acquired 2002 JBC Startup World-Class Bromine Position Resource Managed In Fine Chemicals Market Managed Goal Long Time In Motion Keep Building Momentum Bromine Specialties Pharma Int’s Leading Bromine Company In The World High Volume Bromides MeBr Related Products Br F R EDB For TEL – Ethyl Beginnings Global Leader in BrFR 15

16. Continue To Build & Drive The World’s Lowest Cost Global Bromine Sourcing Network • Maximize Value While Ensuring Leading Share In All Significant Bromine Consuming Uses • Lead In Developing New Applications For High Value Bromine Specialties • Secure Advantage From Technologies Borrowing Bromides Bromine Chemicals: Business Strategies

17. Fine Chemicals Strategies Serve Chemistry To Solve Customer Problems ------------------------------------------------------- Widen & Deepen Access Into Key End Markets: Pharma & Ag ------------------------------------------------------- Drive To Actives: Highest Chemistry Value Add Fine Chemistry Services Industrial Specialties StrategicGrowth Manage for Cash New Strategy Potentials ? Bromine Chemicals Leading Bromine Company Worldwide

18. Fine Chemistry Services Model Customer Needs & Opportunities Fine Chemistry Services Ag ALB Intermediates Custom Mfr Contract Research Pharma ALB Intermediates Custom Mfr Contract Research Industrial Specialties Personal Care Photo Chems Flavors / Fragrances Etc. ALB Actives (APIs) Ibuprofen, Naproxen ALB Actives Methyl Bromide

19. Albemarle’s Fine Chemistry Services Area Of Major Strategic Change 2001 3 Pharma Products 3 Ag Products Leading BFC’s In EU 1 cGMP Facility Several New Prod’s In Pipeline 2004 Historic Pharma/Ag/BFC Products Continued Pressures On IBP / NPX Leading US Custom Mfr 3 Research Facilities (2 US, 1 EU) 3 cGMP Facilities 7 Flexible Multi-Product Sites 90+ New Products In Pipeline Globally Leading Capabilities Capabilities Products Flexible Plants’ Utilization Up Profit Up approx $10 MM in ’04 v. ’02 Stepping Up in ’05: • Utilizations / Better Mix • Pipeline Productivity • New Products / Capabilities • Owning Our Niches Success w/ Specialty API’s Profit Up approx $3 MM in ’04 v. ’02

20. Fine Chemistry Services New Product Pipeline 90 products in our pharma pipeline 26 20 15 15 10 4 Patent Protected Pre-Clinical Generic Phase I Phase II Phase III +4% +22% +61%

21. Fine Chemistry Services:Build Synergistically Customer Needs & Opportunities Gain More Market Access Fine Chemistry Services Other Market Servicing Capability Other Market Servicing Capability Ag ALB Intermediates Custom Mfr Contract Research Pharma ALB Intermediates Custom Mfr Contract Research Industrial Specialties Further Downstream in Market to Higher Chemistry Value Further Downstream in Market to Higher Chemistry Value

22. Profit Growth In Fine Chemicals Last 3 quarters 2004 vs. 2003 up 3% • Change in operating profit versus prior year, excluding specials. 2004 data unaudited.

23. Fine Chemicals: Investment Considerations • Strong Positions Driving Our Strategic Successes • Global Bromine Leadership – Tightening Supply Environment • Broad Fine Chemistry Service Business Capabilities: • Developed, Entrenched Service Model Satisfying Our Targeted Client Base • Leverages Corporate Chemistry / Process Development Foundation Strength • Drives Us Into Attractive Pharma / Ag Markets For Chemistry / Innovation • One Of Relatively Few Worldwide With Pharma / Ag Revenues > $200 MM • Sound Strategies Drive Improved Returns & Sustain Growth • Disciplined Corporate Cost Focus – Improving Return on Assets • M&A Activities Continue to Target Bolt-On Acquisitions, But Not Essential To Long Term Fine Chemicals Success • Strong Accountable Team • Mitigating Near-Term Exceptional Situations • Successfully Managing Portfolio Rejuvenation

24. Albemarle CorporationFine Chemicals UBS Grass Roots Chemical Conference February 16, 2005 John Nicols Vice President Fine Chemicals